MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 238 filers reported holding MYRIAD GENETICS INC in Q1 2017. The put-call ratio across all filers is 2.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $430,000 | -68.6% | 21,762 | -77.3% | 0.04% | -76.7% |
| Q1 2020 | $1,371,000 | +55.8% | 95,850 | +216.3% | 0.15% | +233.3% |
| Q4 2018 | $880,000 | -63.1% | 30,300 | -52.5% | 0.04% | -8.2% |
| Q2 2018 | $2,384,000 | +241.5% | 63,800 | +75.3% | 0.05% | +345.5% |
| Q1 2017 | $698,000 | -55.8% | 36,400 | -61.6% | 0.01% | -72.5% |
| Q4 2016 | $1,578,000 | +33.1% | 94,700 | +244.4% | 0.04% | -44.4% |
| Q4 2015 | $1,186,000 | -49.7% | 27,500 | -56.3% | 0.07% | -59.3% |
| Q3 2015 | $2,357,000 | +623.0% | 62,900 | +555.2% | 0.18% | +254.0% |
| Q4 2014 | $326,000 | +28.3% | 9,600 | +45.5% | 0.05% | +2.0% |
| Q3 2014 | $254,000 | -85.3% | 6,600 | -87.0% | 0.05% | -40.2% |
| Q1 2014 | $1,730,000 | – | 50,600 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |